Cardiol Therapeutics Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
0.00 |
0.00 |
1.04 |
21.52 |
99.63 |
162.88 |
| Przychód Δ r/r |
0.00% |
0.00% |
inf% |
1967.51% |
362.88% |
63.47% |
| Przychód (min) |
0.00 |
0.00 |
1.04 |
21.52 |
99.63 |
162.88 |
| Przychód (max) |
0.00 |
0.00 |
1.04 |
21.52 |
99.63 |
162.88 |
| EBITDA (średnia) |
0.00 |
0.00 |
0.62 |
12.91 |
59.78 |
97.73 |
| EBIT (średnia) |
0.00 |
0.00 |
0.62 |
12.91 |
59.78 |
97.73 |
| EBIT % |
0.00% |
0.00% |
60.00% |
60.00% |
60.00% |
60.00% |
| Zysk netto (średni) |
-28.21 |
-29.21 |
-28.89 |
-24.06 |
20.58 |
53.01 |
| Zysk netto % |
-inf% |
-inf% |
-2774.71% |
-111.79% |
20.66% |
32.54% |
| EPS (średnia) |
-0.41 |
-0.42 |
-0.40 |
-0.34 |
0.29 |
0.74 |
| Liczba analityków (Przychody) |
0 |
0 |
4 |
2 |
1 |
1 |
| Liczba analityków (EPS) |
2 |
2 |
2 |
1 |
1 |
1 |
| symbol |
CRDL |
CRDL |
CRDL |
CRDL |
CRDL |
CRDL |